Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer
NCT01858805
·
clinicaltrials.gov ↗
COMPLETED
Status
123
Enrollment
OTHER
Sponsor class
Conditions
Resectable Esophageal Cancer
Interventions
PROCEDURE:
esophagectomy
Sponsor
Universitätsklinikum Hamburg-Eppendorf